Dr. Rajesh Grover
Chief Growth Officer
Dr. Rajesh Grover is a serial entrepreneur, scientist, and strategic advisor with a distinguished career spanning life sciences, biotechnology, healthcare, advanced technologies, and resource innovation. As Chief Growth Officer, he leads strategic growth initiatives, global partnerships, investor engagement, and commercialization efforts, helping transform breakthrough technologies into scalable business successes.
For more than 25 years, Dr. Grover has successfully guided innovation, capital formation, and business growth by leveraging his leadership experience and international network. As a scientist-entrepreneur, he approaches some of humanity's greatest challenges through the lens of chemistry and applied innovation from hydrogen as a next-generation energy source and advanced water purification technologies to the extraction and utilization of critical minerals essential for global progress.
Through leadership roles in venture advisory groups, investor and family office forums, entrepreneurial ecosystems, and participation in leading global industry and mining conferences, Dr. Grover has cultivated an extensive network of entrepreneurs, CEOs, investors, family offices, policymakers, and institutional leaders. His ability to connect capital, technology, and strategic partnerships has contributed to initiatives generating more than $100 million in economic impact while advancing solutions for human health, sustainability, and industrial development.
A unique aspect of Dr. Grover's leadership is his deep understanding of the human factors that drive business success. By combining growth strategy with insights into trust, uncertainty, identity, and decision-making behavior, he has helped organizations navigate complex negotiations, accelerate market adoption, secure investment, and build enduring strategic partnerships.
Dr. Grover's scientific contributions have been published in leading journals, including Science, Proceedings of the National Academy of Sciences (PNAS), Journal of the American Medical Association (JAMA), Nature Reviews, and the American Journal of Transplantation. He is an inventor on multiple patents, and his work has contributed to advances in drug discovery, biotechnology, and translational science.
He earned an M.S. in Biomedical Engineering, Chemistry, and Biochemistry from the Indian Institute of Technology (IIT) Delhi, a Ph.D. in Drug Discovery and Biomedical Resonance from the Central Drug Research Institute, and completed a Postdoctoral Fellowship in Immunology and Chemical Biology at the prestigious Scripps Research, CA, USA..
His entrepreneurial philosophy is best captured by the belief: "A breakthrough today was a crazy idea yesterday."